A Novel Method to Identify Differential Pathways in Hippocampus Alzheimer’s Disease

Background Alzheimer’s disease (AD) is the most common type of dementia. The objective of this paper is to propose a novel method to identify differential pathways in hippocampus AD. Material/Methods We proposed a combined method by merging existed methods. Firstly, pathways were identified by four known methods (DAVID, the neaGUI package, the pathway-based co-expressed method, and the pathway network approach), and differential pathways were evaluated through setting weight thresholds. Subsequently, we combined all pathways by a rank-based algorithm and called the method the combined method. Finally, common differential pathways across two or more of five methods were selected. Results Pathways obtained from different methods were also different. The combined method obtained 1639 pathways and 596 differential pathways, which included all pathways gained from the four existing methods; hence, the novel method solved the problem of inconsistent results. Besides, a total of 13 common pathways were identified, such as metabolism, immune system, and cell cycle. Conclusions We have proposed a novel method by combining four existing methods based on a rank product algorithm, and identified 13 significant differential pathways based on it. These differential pathways might provide insight into treatment and diagnosis of hippocampus AD.

[1]  S. M. de la Monte,et al.  Brain metabolic dysfunction at the core of Alzheimer's disease. , 2014, Biochemical pharmacology.

[2]  Christina Kendziorski,et al.  R/EBcoexpress: an empirical Bayesian framework for discovering differential co-expression , 2012, Bioinform..

[3]  Lincoln Stein,et al.  Reactome: a database of reactions, pathways and biological processes , 2010, Nucleic Acids Res..

[4]  G. Pawelec,et al.  Immune profiling of Alzheimer patients , 2012, Journal of Neuroimmunology.

[5]  C. Lyketsos,et al.  Plasma neopterin level as a marker of peripheral immune activation in amnestic mild cognitive impairment and Alzheimer's disease , 2013, International journal of geriatric psychiatry.

[6]  Eric M Reiman,et al.  Gene expression profiles in anatomically and functionally distinct regions of the normal aged human brain. , 2007, Physiological genomics.

[7]  Chao Wu,et al.  Integrating gene expression and protein-protein interaction network to prioritize cancer-associated genes , 2012, BMC Bioinformatics.

[8]  Yingying Jia,et al.  Meta-Analysis of Ubiquilin1 Gene Polymorphism and Alzheimer’s Disease Risk , 2014, Medical science monitor : international medical journal of experimental and clinical research.

[9]  Peter Schönknecht,et al.  Type II diabetes in mild cognitive impairment and Alzheimer's disease: results from a prospective population-based study in Germany. , 2009, Journal of Alzheimer's disease : JAD.

[10]  Zhichun Chen,et al.  Decoding Alzheimer's disease from perturbed cerebral glucose metabolism: Implications for diagnostic and therapeutic strategies , 2013, Progress in Neurobiology.

[11]  W. Markesbery,et al.  Incipient Alzheimer's disease: Microarray correlation analyses reveal major transcriptional and tumor suppressor responses , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[12]  C. Orengo,et al.  Microarray analysis after RNA amplification can detect pronounced differences in gene expression using limma , 2006, BMC Genomics.

[13]  Michael S. McGrath,et al.  Systemic immune system alterations in early stages of Alzheimer's disease , 2013, Journal of Neuroimmunology.

[14]  M. Barbagallo,et al.  Systemic immune responses in Alzheimer's disease: in vitro mononuclear cell activation and cytokine production. , 2010, Journal of Alzheimer's disease : JAD.

[15]  J. Bao,et al.  Associations Between Genetic Variants in 19p13 and 19q13 Regions and Susceptibility to Alzheimer Disease: A Meta-Analysis , 2016, Medical science monitor : international medical journal of experimental and clinical research.

[16]  Melanie J. Lucero,et al.  Running reduces stress and enhances cell genesis in aged mice , 2011, Neurobiology of Aging.

[17]  Yun-xia Yu,et al.  Polymorphisms of CHAT but not TFAM or VR22 are Associated with Alzheimer Disease Risk , 2016, Medical science monitor : international medical journal of experimental and clinical research.

[18]  Eric M. Blalock,et al.  Microarray analyses of laser-captured hippocampus reveal distinct gray and white matter signatures associated with incipient Alzheimer's disease , 2011, Journal of Chemical Neuroanatomy.

[19]  G. Kemmler,et al.  Two Blood Monocytic Biomarkers (CCL15 and p21) Combined with the Mini-Mental State Examination Discriminate Alzheimer's Disease Patients from Healthy Subjects , 2011, Dementia and Geriatric Cognitive Disorders Extra.

[20]  T. Speed,et al.  Summaries of Affymetrix GeneChip probe level data. , 2003, Nucleic acids research.

[21]  Damian Szklarczyk,et al.  The STRING database in 2011: functional interaction networks of proteins, globally integrated and scored , 2010, Nucleic Acids Res..

[22]  Nick C Fox,et al.  Clinical and biomarker changes in dominantly inherited Alzheimer's disease. , 2012, The New England journal of medicine.

[23]  Yuren Jiang,et al.  Butyrylcholinesterase K Variant and Alzheimer’s Disease Risk: A Meta-Analysis , 2015, Medical science monitor : international medical journal of experimental and clinical research.

[24]  Winnie S. Liang,et al.  Alzheimer's disease is associated with reduced expression of energy metabolism genes in posterior cingulate neurons , 2008, Proceedings of the National Academy of Sciences.

[25]  Jaesung Lee,et al.  Efficient multivariate feature filter using conditional mutual information , 2012 .

[26]  Terence P. Speed,et al.  A comparison of normalization methods for high density oligonucleotide array data based on variance and bias , 2003, Bioinform..

[27]  E. McAuley,et al.  Aerobic fitness is associated with hippocampal volume in elderly humans , 2009, Hippocampus.

[28]  Roger N Rosenberg,et al.  Genome-wide association studies in Alzheimer disease. , 2008, Archives of neurology.

[29]  Richard Mayeux,et al.  Relation of diabetes to mild cognitive impairment. , 2007, Archives of neurology.

[30]  J. Morillas-Ruiz,et al.  A Review: Inflammatory Process in Alzheimer's Disease, Role of Cytokines , 2012, TheScientificWorldJournal.

[31]  Douglas A. Hosack,et al.  Identifying biological themes within lists of genes with EASE , 2003, Genome Biology.

[32]  S. Jo,et al.  Identification of peripheral inflammatory markers between normal control and Alzheimer's disease , 2011, BMC neurology.

[33]  John D. Minna,et al.  Probe mapping across multiple microarray platforms , 2012, Briefings Bioinform..

[34]  T. Wisniewski,et al.  The Innate Immune System in Alzheimer's Disease , 2013, International journal of cell biology.

[35]  L. Beckett,et al.  Annual Incidence of Alzheimer Disease in the United States Projected to the Years 2000 Through 2050 , 2001, Alzheimer disease and associated disorders.

[36]  E Skafidas,et al.  Predicting the diagnosis of autism spectrum disorder using gene pathway analysis , 2012, Molecular Psychiatry.

[37]  Dimitrios Kapogiannis,et al.  Disrupted energy metabolism and neuronal circuit dysfunction in cognitive impairment and Alzheimer's disease , 2011, The Lancet Neurology.

[38]  Hugues Bersini,et al.  Unlocking the potential of publicly available microarray data using inSilicoDb and inSilicoMerging R/Bioconductor packages , 2012, BMC Bioinformatics.

[39]  Christina Kendziorski,et al.  An Empirical Bayesian Approach for Identifying Differential Coexpression in High‐Throughput Experiments , 2012, Biometrics.

[40]  Brad T. Sherman,et al.  Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources , 2008, Nature Protocols.

[41]  Steven C. Lawlor,et al.  MAPPFinder: using Gene Ontology and GenMAPP to create a global gene-expression profile from microarray data , 2003, Genome Biology.

[42]  J. Morris,et al.  The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease , 2011, Alzheimer's & Dementia.

[43]  Ronald C. Petersen,et al.  Identification of Altered Metabolic Pathways in Plasma and CSF in Mild Cognitive Impairment and Alzheimer’s Disease Using Metabolomics , 2013, PloS one.

[44]  Adrian E. Raftery,et al.  Model-Based Clustering, Discriminant Analysis, and Density Estimation , 2002 .

[45]  Rainer Breitling,et al.  Rank products: a simple, yet powerful, new method to detect differentially regulated genes in replicated microarray experiments , 2004, FEBS letters.

[46]  L. Tan,et al.  Increased expressions of TLR2 and TLR4 on peripheral blood mononuclear cells from patients with Alzheimer's disease , 2012, Journal of the Neurological Sciences.